Navigation Links
Vitamin E Helps Treat Common Liver Disease
Date:4/28/2010

But only effective in less than half of cases, study finds

WEDNESDAY, April 28 (HealthDay News) -- A new study has identified vitamin E as a treatment that can provide relief for many of the estimated 10 million Americans who have the most common chronic liver disease.

"This clearly shows that vitamin E is effective for treatment of patients with nonalcoholic steatohepatitis who don't have active diabetes," said study author Dr. Arun J. Sanyal, chairman of the division of gastroenterology, hepatology and nutrition at Virginia Commonwealth University. A report on the trial is published in the April 28 online edition of the New England Journal of Medicine.

A second drug tested in the trial, the diabetes medication pioglitazone (Actos), provided some relief but did not meet the benchmarks set in the study, Sanyal added.

The trial did not test the two treatments head-to-head. Instead, each was tested against a placebo, an inactive substance. Those treatments were chosen for the trial because older studies indicated that insulin resistance was an important aspect of the condition, which is less formally called nonalcoholic fatty liver disease, while oxidative stress also plays an important role, Sanyal said. Actos reduces insulin resistance, while vitamin E is an antioxidant.

The study indicates that perhaps 43 percent of people with the condition who do not have diabetes will be helped by daily doses of vitamin E, Sanyal said. While some medications have shown promise in early tests, there is no drug approved by the U.S. Food and Drug Administration for treatment of nonalcoholic fatty liver disease.

The build-up of fatty deposits in the liver, which are caused by the condition, often creates only minor health problems. But the disease can progress to cirrhosis, and a life-threatening deterioration of liver function.

The 96-week study included 247 adults with the condition, none of whom had diabetes. Some patients were given 30 milligrams a day of Actos, some were given 800 International Units of vitamin E daily and others were given a placebo. A significant rate of improvement in markers of the disease, such as inflammation, was seen in 43 percent of those getting vitamin E, compared to 19 percent of those getting placebo. Similar improvement was seen in 34 percent of those getting Actos, compared to 19 percent of those getting placebo, a difference that was not statistically significant.

Actos might be a viable treatment for some people with fatty liver disease, but the study found its use was associated with significant weight gain that continued throughout the study, Sanyal said.

And vitamin E "should not be regarded as a panacea," he said. "It doesn't mean that everyone should start popping vitamin E."

Because of the high percentage of people who did not respond to vitamin E, that treatment should be done only under a doctor's supervision, with follow-ups to determine whether the treatment is working, Sanyal said.

And while no adverse side effects of the vitamin E regimen were seen, the small size of the study and its relatively short duration do not provide definitive evidence against such problems occurring, he said.

"Vitamin E will be a weapon in the arsenal that doctors have to treat patients with nonalcoholic steatohepatitis," said Patricia R. Robuck, a senior advisor at the U.S. National Institute of Diabetes and Digestive and Kidney Diseases, "but there are important cautions to be observed."

The trial included only "a relatively healthy population with no diabetes and no cardiovascular disease," Robuck said. "For those people, it can be an important treatment. But should everyone start taking vitamin E? Absolutely not. It should be done under a doctor's care and with careful supervision."

More information

To learn more about fatty liver disease, visit the American Liver Foundation.



SOURCES: Arun J. Sanyal, M.D., chairman, division of gastroenterology, hepatology and nutrition, Virginia Commonwealth University, Richmond, Va.; Patricia R. Robuck, Ph.D., senior advisor, U.S. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md.; April 28, 2010, New England Journal of Medicine, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. High-Dose Vitamin B Risky for Diabetics With Kidney Disease
2. Instaflex Announces Partnership with GNC, the Nation's Leading Vitamin and Supplement Retailer
3. Better vitamin D status could mean better quality of life for seniors
4. Vitamin K may protect against developing non-Hodgkins lymphoma, say Mayo Clinic researchers
5. B-vitamins Help Protect Against Stroke, Heart Disease
6. Low vitamin D levels associated with more asthma symptoms and medication use
7. Vitamins C, E Wont Cut Risk of Pregnancy-Linked Hypertension
8. Minority Kids Lack Enough Vitamin D
9. SumNuts Vitamin Nuts Launched, Enhanced with Vitamin D3 and Calcium
10. Too Many Infants Short on Vitamin D
11. Study: Low Levels of Vitamin D Linked to Higher Rates of Asthma in African American Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... The Gallery ... Kevin Sadati, is pleased to announce a new treatment option called Vivace Microneedling. ... their face, neck, and body through a virtually pain-free, non-surgical treatment. Vivace Microneedling ...
(Date:5/23/2017)... ... May 23, 2017 , ... New patients from Charleston, SC, are ... dentist practicing in Mt. Pleasant, SC, with or without a referral. A full mouth ... with missing teeth in Charleston, SC. Those who suffer from gum disease, ...
(Date:5/23/2017)... WI (PRWEB) , ... May 23, 2017 , ... Patients ... to call Dr. Angela Cotey’s practice to schedule an appointment, with or without a ... and frequently offers pulpotomy treatments to pediatric patients as a healthy alternative to a ...
(Date:5/22/2017)... PA (PRWEB) , ... May 22, 2017 , ... An ... to write with a pen. "My wife’s hand was damaged in a firework accident, ... something that helps people with manual problems." , He then designed and created a ...
(Date:5/22/2017)... ... May 22, 2017 , ... ... larger group investing in InsightRX, an early stage company in San Francisco that ... pharmacological characteristics. Greatpoint Ventures Innovation Fund acted as the lead investor ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
Breaking Medicine Technology: